1. The lung extracellular matrix protein landscape in severe early-onset and moderate chronic obstructive pulmonary disease.
- Author
-
Joglekar MM, Bekker NJ, Koloko Ngassie ML, Vonk JM, Borghuis T, Reinders-Luinge M, Bakker J, Woldhuis RR, Pouwels SD, Melgert BN, Timens W, Brandsma CA, and Burgess JK
- Subjects
- Humans, Male, Middle Aged, Female, Aged, Versicans metabolism, Latent TGF-beta Binding Proteins metabolism, Latent TGF-beta Binding Proteins genetics, Lumican metabolism, Collagen Type I metabolism, Calcium-Binding Proteins metabolism, Collagen Type I, alpha 1 Chain, Severity of Illness Index, Collagen Type VI metabolism, Pulmonary Disease, Chronic Obstructive metabolism, Pulmonary Disease, Chronic Obstructive pathology, Lung metabolism, Lung pathology, Extracellular Matrix Proteins metabolism, Elastin metabolism, Decorin metabolism, Extracellular Matrix metabolism, Extracellular Matrix pathology
- Abstract
Extracellular matrix (ECM) remodeling has been implicated in the irreversible obstruction of airways and destruction of alveolar tissue in chronic obstructive pulmonary disease (COPD). Studies investigating differences in the lung ECM in COPD have mainly focused on some collagens and elastin, leaving an array of ECM components unexplored. We investigated the differences in the ECM landscape comparing severe-early onset (SEO)-COPD and moderate COPD to control lung tissue for collagen type I α chain 1 (COL1A1), collagen type VI α chain 1 (COL6A1); collagen type VI α chain 2 (COL6A2), collagen type XIV α chain 1 (COL14A1), fibulin 2 and 5 (FBLN2 and FBLN5), latent transforming growth factor β binding protein 4 (LTBP4), lumican (LUM), versican (VCAN), decorin (DCN), and elastin (ELN) using image analysis and statistical modeling. Percentage area and/or mean intensity of expression of LUM in the parenchyma, and COL1A1, FBLN2, LTBP4, DCN, and VCAN in the airway walls, was proportionally lower in COPD compared to controls. Lowered levels of most ECM proteins were associated with decreasing forced expiratory volume in 1 s (FEV
1 ) measurements, indicating a relationship with disease severity. Furthermore, we identified six unique ECM signatures where LUM and COL6A1 in parenchyma and COL1A1, FBLN5, DCN, and VCAN in airway walls appear essential in reflecting the presence and severity of COPD. These signatures emphasize the need to examine groups of proteins to represent an overall difference in the ECM landscape in COPD that are more likely to be related to functional effects than individual proteins. Our study revealed differences in the lung ECM landscape between control and COPD and between SEO and moderate COPD signifying distinct pathological processes in the different subgroups. NEW & NOTEWORTHY Our study identified chronic obstructive pulmonary disease (COPD)-associated differences in the lung extracellular matrix (ECM) composition. We highlight the compartmental differences in the ECM landscape in different subtypes of COPD. The most prominent differences were observed for severe-early onset COPD. Moreover, we identified unique ECM signatures that describe airway walls and parenchyma providing insight into the intertwined nature and complexity of ECM changes in COPD that together drive ECM remodeling and may contribute to disease pathogenesis.- Published
- 2024
- Full Text
- View/download PDF